We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00807144
Recruitment Status : Unknown
Verified June 2011 by Hammersmith Hospitals NHS Trust.
Recruitment status was:  Recruiting
First Posted : December 11, 2008
Last Update Posted : June 28, 2011
Information provided by:
Hammersmith Hospitals NHS Trust

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2012
  Estimated Study Completion Date : March 2012